There has been a revolution in treatment advances for patients with cancer. These include explosive development and use of both targeted therapy and immune based therapies. The most effective use of these new treatments require access to advanced tissue and blood diagnostics. Unfortunately many patients and oncologists cannot easily access these new diagnostics advances because they live in areas with limited access to laboratory services.
Protean BioDiagnostics is committed to creating and deploying the latest and highest quality laboratory diagnostic tools. We work with physicians to support them in providing the best possible care for their patients, regardless of where they live.
Protean BioDiagnostics is committed to creating and deploying the latest and highest quality laboratory diagnostic tools. We work with physicians to support them in providing the best possible care for their patients, regardless of where they live.
Location: United States, Florida, Orlando
Employees: 11-50
Phone: (754) 242-9682
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | University... | incubator.... |
Mentions in press and media 1
| Date | Title | Description |
| 23.02.2021 | Biocept and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept’s Target Selector™ Assay Kit for Non-Small Cell Lung Cancer Patients | SAN DIEGO--(BUSINESS WIRE)--Feb 23, 2021-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, will collaborate with Protean BioDiagnostics Inc. to research the ability of Biocept’s Target... |